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Data is presented showing expression of non-conventional (NC)
heavy chain forms of B27 in synovial tissues from SpA patients.
Data is presented showing the expression patterns of NC-B27 in
joint, gastrointestinal and lymphoid tissues from B27 transgenic
(TG1) rats with M. tuberculosis-induced SpA. Expression of NC-B27
was determined by immunohistochemistry and ﬂow cytometry
using HC10 and HD6 antibodies. These data are the extension of
the data presented and discussed in “Non-conventional forms of
HLA-B27 are expressed in Spondyloarthritis joints and gut tissue”
(O. Rysnik, K. McHugh, L. M. van Duivenvoorde, M. N. van Tok,
G. Guggino, J. D. Taurog, S. Kollnberger, F. Ciccia, D. L. Baeten,
P. Bowness, 2016) [1].
& 2016 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).is an open access article under the CC BY license
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Value of the data
 Data presented in this article conﬁrm the role of NC-B27 in SpA pathogenesis in both human and
transgenic rats.
 This data serves as a benchmark for future studies on the pathogenic role of NC-B27 in SpA.
 The data is valuable for future studies on development of novel treatment strategies for SpA.1. Data
The immunohistochemistry data show expression of NC-B27 forms (HC10 and HD6 staining) in
synovial tissues from B27þve SpA patients (Fig. 1), and in joint and gastrointestinal tissues from B27ning of both frozen and parafﬁn-ﬁxed synovial tissues from patients with HLA-B27-positive
O. Rysnik et al. / Data in Brief 9 (2016) 100–111102TG1 rats withM.tb-induced SpA and in healthy WT and B7 TG controls (Figs. 2–7). The ﬂow cytometry
data describe and quantify the expression of HC10- and HD6-reactive NC-B27 molecules in spleens
and lymph nodes from B27 TG1 rats in a spontaneous and M.tb-induced SpA before and after disease
onset (Figs. 8–10).2. Experimental design, materials and methods
2.1. Patients
Human synovial tissue samples were obtained with informed consent and appropriate ethical
permission, from B27þ SpA patients, including 1 with Ankylosing Spondylitis (AS) fulﬁlling the New
York classiﬁcation criteria [2], and patients with Rheumatoid Arthritis (RA) fulﬁlling the EULAR/ACR
criteria [3].Fig. 2. (A–D) shows HC10 staining of axial joints from B27 TG1 rats with M.tb-induced SpA. Staining was observed particularly
in cell inﬁltrates at the junction between the vertebrae, connective tissue and annulus ﬁbrosus. We did not observe HC10
staining in ankle or tail joints from healthy Lewis WT rats (Fig. 2E and F).
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B27 transgenic (TG) rats ﬁrst generated by Hammer and colleagues spontaneously develop
inﬂammatory gut and joint disease [4]. More recently additional human β2mwas introduced, i.e. (21-
3283-2) F1 HLA-B27/Huβ2m [5]. We term this model, studied here, as B27 TG1. A higher proportion
of these B27 TG1 male rats spontaneously develop arthritis (70%, 4–6 months of age) and spon-
dylitis (30–50%, 7–9 months of age) without symptoms of gut inﬂammation [5–7]. Early andFig. 3. We did not observe HC10 or HD6 staining in ankle joints from Lewis WT rats with adjuvant-induced arthritis (AIA).
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low doses of M. tuberculosis (hereafter referred to as “M.tb-induced arthritis and spondylitis”) [8,9].
Splenocytes, lymph node cells (LNs), ankle, tail joints and GI tissues were isolated from B27 TG1 rats
with spontaneous or induced SpA at age 4–15 weeks. ForM.tb-induced arthritis and spondylitis [8], 6
week-old B27 TG1 rats were immunized with 30–45 μg of heat-inactivated M.tb in incomplete
Freund's adjuvant [8,9]. (120-4283-2)F1 HLA-B7/Huβ2m TG (B7 TG) and Lewis wild type (WT)
animals þ/ 200 μg of heat-inactivated M.tb in IFA (adjuvant-induced arthritis, AIA model) were
used as controls. All animals were bred and housed at the animal facility of the AMC, University of
Amsterdam, Netherlands. All animal procedures were carried out in compliance with Institutional
Standards for Human Care and Use of Laboratory Animals.
2.3. Antibodies
The HC10 antibody stains many or all heavy chain forms (but not beta-2-microglobulin-associated
conventional forms) of most human HLA-B and some HLA-A alleles, but does not cross react with rat
MHC [10]. HC10 stains HLA-B27 free heavy chains (FHC) including dimers [10,11]. The HD6 antibody
was raised against B27 homodimers using a fully human FAb antibody library (kindly provided by
Dynax, MA, USA) as previously described [11,12], and is more speciﬁc for heavy chain forms of HLA-
B27. HD6r (same speciﬁcity as HD6 but with rat IgG1 Fc region) was used for some stains.
2.4. Immunohistochemistry of human and rat tissue samples
Human SpA and RA, and rat parafﬁn-embedded synovial tissue samples were prepared as pre-
viously described [6,13,14]. Parafﬁn-embedded tissue sections were blocked using Peroxidase
Blocking Reagent (EnVision™, Dako), than incubated with PBS/1%FBS/10% goat serum and subse-
quently stained overnight with HC10 or HD6 primary mAb. HC10-stained sections were incubated
with HRP-labeled anti-mouse IgG (EnVision™, Dako). HD6-stained sections were incubated with
biotinylated goat anti-mouse IgG1 (Southern Biotech) followed by streptavidin-HRP (Dako). TissueFig. 4. Shows that tissue sections from B27 TG1 rats withM.tb-induced arthritis and spondylitis did not stain with IgG1 isotype
control antibody.
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stained using Mayer's hematoxylin. Slides were visualized using an LSM Zeiss confocal microscope,
scanned using AperioCS2 Scanner and analyzed using Aperio ImageScope software (Leica
Biosystems, UK).
2.5. Flow cytometry
Splenocytes and LNs were freshly isolated and immediately stained as described previously [15].
Cells were incubated in blocking buffer, and then stained with primary antibody (HC10, HD6, ME1 orFig. 5. Shows HC10 staining was detectable on mononuclear cells in small intestinal Peyer's patches, in lymphoid follicles and
in the lamina propria of all transgenic animals. Staining levels were higher for B27 TG1 rats with M.tb-induced arthritis and
spondylitis compared to those without M.tb or healthy B7 TG animals.
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Invitrogen). Subsequently, cells were stained for the phenotypic surface markers: CD4 and CD8α or
CD45R and MHCII, or CD11b/c. Dead cells were excluded using ﬁxable viability dye eFluor
s
780
(eBioscience). Flow cytometric analysis was performed with BD FACS Canto and data were analyzed
using FlowJo Software (TreeStar). Staining was performed in triplicates. Error bars were calculated
based on SD mean of the values if 3Z animals per group. P values were determined using non-
parametric Mann–Whitney test.Fig. 6. Speciﬁc HC10 staining was also seen in the colon.
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Biomedical Research Center, the Oxford NIHR Biomedical Research Unit (PB).Fig. 7. HD6 stained small and large bowel tissues, although with background staining observed (Fig. 7 and data not shown).
These data show that NC-B27 are expressed in gut tissue in B27 TG1 rats.
Fig. 8. Shows that splenic and lymph node CD45þ/MHCIIþ leukocytes from B27 TG1 rats with M.tb-induced arthritis and
spondylitis expressed very low levels of NC-B27 molecules.
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Fig. 9. Similar results were observed with cells isolated from B27 TG1 lymph nodes þ/ M.tb (Fig. 9A), noting that the CD11b/
cþ cell population was absent (see Fig. 10J). We also investigated HC10 and HD6 staining of splenocytes taken from 8–9 weeks
old B27 TG1 animals with and without M.tb-induced SpA before the appearance of clinical manifestations. HC10 was not
signiﬁcantly altered in splenic CD11b/cþ , CD8αþ or CD4þ cells, or on cell populations from LNs (Fig. 9B–D). However, we
observed an increase in HD6 staining on splenic CD4þ cells after M.tb treatment (Fig. 9C right-hand panel). No HC10 or HD6
staining was observed in splenic and LN cells from age-matched Lewis WT rats (data not shown). Splenic and LN cells from age-
matched B7 TG rats stained with HC10, but not HD6, to a similar degree compared with B27 TG1 animals (spontaneous model)
(Fig. 9A).
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Fig. 10. Shows the gating strategy for analysis of spleen and lymph node cell populations studied by FACS.
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